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Unraveling the Mechanistic
Details of Topoisomerases
In this issue, Shuman and coworkers use methyl- T
phosphonates as a nonnative substrate to investigate a
the mechanism of type IB topoisomerases (Tian et al., p
2005, this issue of Structure). A surprising gain-of- d
function result was critical to assigning a catalytic p
role to an active site arginine. a
t
DNA topoisomerases are important enzymes that alter t
the topology of DNA and are involved in many different a
DNA transactions. All topoisomerases perform a multi- a
step catalytic cycle that involves cleavage of one or t
both DNA strands, passage of the strand(s) through the
break, followed by religation of the cleaved DNA mole- a
cule. Topoisomerases form a transient phosphotyrosine t
intermediate with one end of the broken strand while i
the other end is kept sequestered in the molecule. Fail- a
ure to complete the cycle would produce DNA damage s
that could result in cell death. This has lead to the de- s
velopment of a type of powerful chemotherapeutic that a
interferes with topoisomerases by stabilizing the DNA/ S
protein covalent intermediate and hence poisoning the f
cell (for reviews see Champoux, 2001; Corbett and t
Berger, 2004). o
Topoisomerases are classified into two types de- g
pending on whether they cleave one or both strands of g
the target DNA. Details of the mechanism of topoisom- c
erases have emerged over the last few years via a vari- m
ety of different experimental techniques, ranging from g
biochemical approaches to structural studies and, s
more recently, single-molecule studies (Corbett and t
Berger, 2004). Despite this, the cleavage and religation a
reactions are still not well understood for most topo- t
isomerases due to the difficulty of studying a transient n
reaction in enzymes that display little or no sequence t
specificity. The exception is vaccinia virus topoisomer- T
ase I, a type IB topoisomerase. Type IB enzymes form h
pa 3#-phosphotyrosyl intermediate and change the DNAopology by a “controlled rotation” mechanism (Cham-
oux, 2001). Structures of human and vaccinia virus to-
oisomerase I have shown that despite their great dif-
erence in size, the active site is essentially identical in
oth cases (Cheng et al., 1998; Redinbo et al., 1998).
he structures of human topoisomerase I in covalent
nd noncovalent complex with DNA have helped pin-
oint the nature of the protein/DNA interactions (Re-
inbo et al., 1998). The active site contains a catalytic
entad: the active site tyrosine, two arginines, a lysine,
nd a histidine (Corbett and Berger, 2004). Aside from
he histidine, these residues are conserved in all type IB
opoisomerases. Interestingly, type IB topoisomerases
nd tyrosine recombinases, such as flp and Cre, share
similar active site and most likely a cleavage/religa-
ion mechanism (Cheng et al., 1998).
Vaccinia virus topoisomerase I has turned out to be
n ideal system to study the details of the DNA transes-
erification reaction in type IB enzymes. Aside from be-
ng a small, easy to produce protein, it cleaves DNA at
sequence-specific site. More importantly, it is pos-
ible to use “suicide” substrates and other nonnative
ubstrates that permit kinetic studies and detailed
nalysis of the effects of enzyme mutations. Recently,
human and collaborators introduced the use of modi-
ied oligonucleotides to study the details of the type IB
opoisomerase cleavage reaction. In particular, the use
f methylphosphonates, where the nonbridging oxy-
ens in a phosphate group are replaced by methyl
roups, has proven to be extremely powerful, as the
harge of specific groups can be altered in predeter-
ined ways without introducing a bulky chemical
roup. Using this approach, Shuman and coworkers
howed that protein/DNA interactions at remote loca-
ions from the active site are important for active site
ssembly (Tian et al., 2004). Additionally, they observed
hat vaccinia virus topoisomerase I has a latent DNA
uclease activity that is revealed when the charge of
he scissile phosphate is reduced (Tian et al., 2003).
he effect is stereospecific: the Sp methylphosphonate
as a much more dramatic effect than the Rp methyl-
hosphonate on the hydrolysis reaction. The phenome-
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503non is explained by the electrostatic repulsion of water
from the active site; once the repulsion is reduced,
water can get in and allow hydrolysis of the tyrosine-
methylphosphonate DNA bond.
New results of Shuman and coworkers reported in
this issue using methylphosphonates help further our
understanding of the type IB topoisomerase transester-
ification reaction (Tian et al., 2005). Previously the role
of one of the arginines in the catalytic pentad, R223 in
vaccinia virus topoisomerase I, was undefined while
the other arginine and a lysine were shown to be in-
volved in expulsion of the 5#-oxygen of the leaving DNA
strand. The importance of this arginine is underscored
by the observation that replacement of the arginine
with an alanine has a 105 effect on the transesterifica-
tion reaction. Surprisingly, when the R223A mutant was
studied using a Sp methylphosphonate at the scissile
phosphate, a 200-fold increase in the cleavage of the
modified substrate over the all-phosphodiester sub-
strate was observed. Replacement of the arginine with
a lysine recovered some of the transesterification activ-
ity compared to the alanine mutant. These two findings
strongly support a role of the arginine in charge stabili-
zation; the alanine mutant cannot contribute to charge
buildup stabilization in the transition state, but the re-
duced charge of the methylphosphonate alleviates this
need and allows for the reaction to proceed, albeit in a
less efficient manner. Inserting an Rp methylphospho-
nate at the same position results in different kinetics
that suggests an unexpected need for an Rp oxygen in
the mutants, but not in the wild-type enzyme. Another
surprising finding has to do with the religation reaction.
Use of methylphosphonates showed that there is a
modest requirement for a charge in the religation reac-
tion, suggesting that ionic interactions are not as im-
portant for religation, probably because the proper
alignment of the 5#-OH of the broken strand by protein/
DNA interactions is more important than any charge ef-
fect due to the phosphate.
The results of Tian et al. (2005) help assign a role to
a conserved arginine in the catalytic pentad: it is in-volved in stabilization of the negative charge buildup in
the phosphate group in the transition state. This result
furthers our understanding of the catalytic mechanism
of type IB topoisomerases and, by inference, of tyro-
sine recombinases. It also shows the importance of
modifying the substrate, not only the enzyme, to ad-
dress mechanistic questions. In this particular instance,
the gain of function observed, namely the increase in
hydrolysis of the phosphotyrosine intermediate, pro-
vided an invaluable observation needed to unravel the
role of the arginine. Finally, it shows the power, and
need, of a combined approach of structural biology and
biochemistry to answer key questions in structure/
function relationships. The new knowledge garnered
from the present work together with all the past work
of many groups is starting to bring our understanding
of topoisomerases to a level that only a few years ago
was unthinkable.
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